Skip to main content

Advertisement

SpringerLink
Log in

Acquired resistance to cabergoline: progression from initially responsive micro to macroprolactinoma

  • Published:
Pituitary Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. Behan LA, Draman MS, Moran C, King T, Crowley RK, O’Sullivan EP et al (2009) Secondary resistance to cabergoline therapy in a macroprolactinoma: a case report and literature review. Pituitary Feb 4 (Epub ahead of print)

  2. Di Sarno A, Landi ML, Cappabianca P, Di Salle F, Rossi FW, Pivonello R et al (2001) Resistance to cabergoline as compared with bromocriptine in hyperprolactinemia: prevalence, clinical definition, and therapeutic strategy. J Clin Endocrinol Met 86:5256–5261

    Article  CAS  Google Scholar 

  3. Colao A, Vitale G, Cappabianca P, Briganti F, Ciccarelli A, De Rosa M et al (2004) Outcome of cabergoline treatment in men with prolactinoma: effects of a 24. month treatment on prolactin levels, tumor mass, recovery of pituitary function, and semen analysis. J Clin Endocrinol Met 89:1704–1711

    Article  CAS  Google Scholar 

  4. Olafsdottir A, Schlecht J (2006) Management of resistant prolactinomas. Nat Clin Pract Endocrinol Metab 2:552–561

    Article  CAS  PubMed  Google Scholar 

  5. Filopanti M, Barbieri AM, Angioni AR, Colao A, Gasco V, Grottoli S et al (2008) Dopamine D2 receptor gene polymorphism and response to cabergoline therapy in patients with prolactin-secreting pituitary adenomas. Pharmacogenomics J 8:353–363

    Article  Google Scholar 

  6. Pellegrini I, Rasolonjanahary R, Gunz G, Bertrand P, Delivet S, Jedynak CP et al (1989) Resistance to bromocriptine in prolactinomas. J Clin Endocrinol Met 69:500–509

    Article  CAS  Google Scholar 

  7. Caccavelli L, Feron F, Morange I, Rouer E, Benarous R, Dewailly D, Jaquet P et al (1994) Decrease expression of the two D2 dopamine receptor isoforms in bromocriptin resistant prolactinomas. Neuroendocrinology 60:314–322

    Article  CAS  PubMed  Google Scholar 

  8. Nawar RN, AbdelMannan D, Selman WR, Arafah BM (2008) Analytic review: pituitary tumor apoplexy: a review. J Intensive Care Med 23:75–90

    Article  PubMed  Google Scholar 

  9. Biller BMK, Molitch ME, Vance ML, Cannistraro KB, Davis KR, Simons JA et al (1996) Treatment of prolactin-secreting macroadenomas with once-weekly dopamine agonist cabergoline. J Clin Endocrinol Metab 81:2338–2343

    Article  CAS  PubMed  Google Scholar 

  10. Knoepfelmacher M, Gomes MC, Melo ME, Mendonca BB (2004) Pituitary apoplexy during therapy with cabergoline in an adolescent male with prolactin-secreting macroadenoma. Pituitary 7:83–87

    Article  PubMed  Google Scholar 

  11. Ishay A, Levahar P, Qupty G (2004) Expansion of intratumoral hemorrhage in a patient with macroprolactinoma treated with cabergoline. Endocrinologist 14:126–128

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Endocrinology Deparment, Hospital Universitario Insular de Gran Canaria, Las Palmas de Gran Canaria, 35016, Canary Island, Spain

    M. Alberiche Ruano, M. Boronat Cortés, A. Ojeda Pino, C. Rodriguez Perez, M. Gracía Nuñez, D. Marrero Arencibia & F. J. Novoa Mogollón

Authors
  1. M. Alberiche Ruano
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Boronat Cortés
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Ojeda Pino
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C. Rodriguez Perez
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M. Gracía Nuñez
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. D. Marrero Arencibia
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. F. J. Novoa Mogollón
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Alberiche Ruano.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Alberiche Ruano, M., Boronat Cortés, M., Ojeda Pino, A. et al. Acquired resistance to cabergoline: progression from initially responsive micro to macroprolactinoma. Pituitary 13, 380–382 (2010). https://doi.org/10.1007/s11102-010-0237-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11102-010-0237-4

Keywords

Search

Navigation